Cargando…
Improving Lurasidone Hydrochloride’s Solubility and Stability by Higher-Order Complex Formation with Hydroxypropyl-β-cyclodextrin
The biopharmaceutical classification system groups low-solubility drugs into two groups: II and IV, with high and low permeability, respectively. Most of the new drugs developed for common pathologies present solubility issues. This is the case of lurasidone hydrochloride—a drug used for the treatme...
Autores principales: | Gamboa-Arancibia, María Elena, Caro, Nelson, Gamboa, Alexander, Morales, Javier Octavio, González Casanova, Jorge Enrique, Rojas Gómez, Diana Marcela, Miranda-Rojas, Sebastián |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861442/ https://www.ncbi.nlm.nih.gov/pubmed/36678861 http://dx.doi.org/10.3390/pharmaceutics15010232 |
Ejemplares similares
-
Lurasidone hydrochloride
por: Zhang, Hua, et al.
Publicado: (2012) -
Solubility enhancement studies on lurasidone hydrochloride using mixed hydrotropy
por: Madan, Jyotsana R., et al.
Publicado: (2015) -
New Insights on the Role of Connexins and Gap Junctions Channels in Adipose Tissue and Obesity
por: González-Casanova, Jorge Enrique, et al.
Publicado: (2021) -
Effect of 2-Hydroxypropyl-β-cyclodextrin on Solubility of Sparingly Soluble Drug Derivatives of Anthranilic Acid
por: Domańska, Urszula, et al.
Publicado: (2011) -
Enhancement of apixaban's solubility and dissolution rate by inclusion complex (β-cyclodextrin and hydroxypropyl β-cyclodextrin) and computational calculation of their inclusion complexes
por: Salman, Zainab N., et al.
Publicado: (2023)